4th Quarter - Report

TALLEY STRATEGIES LLC for TEVA PHARMACEUTICALS USA, INC.

Period 4th Quarter 2025 Filed Jan 20, 2026 Signed by Stephen Roberts, Attorney & Agent for Filer

Official filing
Firm
TALLEY STRATEGIES LLC
Client
TEVA PHARMACEUTICALS USA, INC.
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to pharmaceutical drug pricing (no specific legislation).

Foreign entity interest: Client is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., as disclosed on the lobbying registration, and as such would benefit from similar opportunities as Client.

LobbyistCovered position, as disclosed
AMBER TALLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Pharmacy PHA

Issues related to pharmaceutical drug pricing (no specific legislation).

Foreign entity interest: Client is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., as disclosed on the lobbying registration, and as such would benefit from similar opportunities as Client.

LobbyistCovered position, as disclosed
AMBER TALLEY —

Contacted: SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.